If you are:
FDB Only When Necessary: AVAILABLE DATA SUGGEST NO KNOWN RISK; OTC PRODUCT, NO FDA PREGNANCY WARNINGS
FDB Only When Necessary: NEONATAL WITHDRAWAL/RESP.DEPRESS. W/CHRONIC OR HIGH DOSE
Precaution: INSUFFICIENT DATA AVAILABLE, MONITOR INFANT FOR RESP DEPRESSION
No Known Risk: LOW LEVELS EXCRETED WITH LOW RISK FOR ADVERSE EFFECTS IN INFANT
An adult over 60:
Contraindication: Neuro/Psych-Generally not recommended in the elderly due to high risk for CNS adverse effects in the elderly and poor effectiveness. May increase fall risk. Avoid treatment with 3 or more CNS active agents. Pulmonary-Respiratory depression risk in the elderly.
management or monitoring precaution: Hepatic-Elderly are more susceptible to hepatotoxicity. Strict adherence to a maximum daily dose of 3000mg is advised.
Giving pentazocine-acetaminophen tablet to a child under 12:
management or monitoring precaution: Use weight based dosing in children less than 12 years.
Severe Precaution: Risk of respiratory depression. No safety and efficacy established age < 12 years.